United Therapeutics Corporation Proceeds from Income Tax Refunds
United Therapeutics Corporation (UTHR) reported Proceeds from Income Tax Refunds of $1.60 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIncomeTaxRefunds · last filed 2021-05-05
- United Therapeutics Corporation proceeds from income tax refunds for the quarter ending 2021-03-31 was $1.60M, a 81.61% decline year-over-year.
- United Therapeutics Corporation proceeds from income tax refunds for the quarter ending 2020-03-31 was $8.70M.
| Period end | Proceeds from Income Tax Refunds 3 month |
|---|---|
| 2021-03-31 | $1.60M 10-Q · filed 2021-05-05 |
| 2020-03-31 | $8.70M 10-Q · filed 2021-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |